Meloxicam-d3

• CAT Number: R004987
• CAS Number: 942047-63-4
• Molecular Formula: C14H13N3O4S2
• Molecular Weight: 354.413
• Purity: ≥95%
• Synonyms: 4-Hydroxy-2-(methyl-d3)-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine?-3-carboxamide 1,1,-Dioxide; Metacam-d3; Mobic-d3; Mobicox-d3; Movalis-d3; Movatec-d3; Parocin-d3
• Storage: 4°C
• IUPAC Name: 4-hydroxy-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2-(trideuteriomethyl)-1$l^{6}
• InChI: InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)/i2D3
• InChIKey: ZRVUJXDFFKFLMG-BMSJAHLVSA-N
• SMILES: CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O

Meloxicam-d3(CAT: R004987) is a deuterium-labeled form of meloxicam. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that belongs to the oxicam class. Its mode of action involves inhibiting the cyclooxygenase (COX) enzymes, particularly COX-2, which are responsible for the production of prostaglandins that cause inflammation, pain, and fever. By reducing prostaglandin levels, meloxicam exerts its pharmacologic action as an analgesic, anti-inflammatory, and antipyretic agent. The deuterium-labeled version, meloxicam-d3, is used in pharmacokinetic and bioavailability studies to track and analyze the metabolism and distribution of meloxicam in the body.